Adrianna Vlachos is a Pediatric Hematologist Oncology specialist and a Pediatrics expert in New Hyde Park, New York. Vlachos has been practicing medicine for over 37 years and is rated as an Elite expert by MediFind in the treatment of Pure Red Cell Aplasia. She is also highly rated in 10 other conditions, according to our data. Her top areas of expertise are Pure Red Cell Aplasia, Aase Syndrome, Aplastic Anemia, Transient Erythroblastopenia of Childhood, and Bone Marrow Transplant. Vlachos is currently accepting new patients.
Jeffrey Lipton is a Pediatric Hematologist Oncology specialist and a Pediatrics expert in New Hyde Park, New York. Lipton has been practicing medicine for over 48 years and is rated as an Elite expert by MediFind in the treatment of Pure Red Cell Aplasia. He is also highly rated in 10 other conditions, according to our data. His top areas of expertise are Aase Syndrome, Pure Red Cell Aplasia, Aplastic Anemia, Anemia, and Bone Marrow Transplant.
Lydie Da Costa practices in Paris, France. Da Costa is rated as an Elite expert by MediFind in the treatment of Pure Red Cell Aplasia. She is also highly rated in 18 other conditions, according to our data. Her top areas of expertise are Aase Syndrome, Pure Red Cell Aplasia, Transient Erythroblastopenia of Childhood, Aplastic Anemia, and Bone Marrow Transplant.
Background: Fanconi anemia (FA) is an inherited disorder. People with FA are more likely to get certain cancers, especially squamous cell carcinoma (SCC). These cancers usually appear first in the mouth, esophagus, and genital and anal areas. Early detection of SCCs may help improve survival rates for people with FA.
Summary: The objective of this clinical trial is to develop a cell therapy for Fanconi Anemia which enables enhanced donor hematopoietic and immune reconstitution with decreased toxicity by transplanting depleted stem cells from a donor after using an experimental antibody treatment called JSP-191 as a part of conditioning. This experimental treatment will hopefully cause fewer side effects than chemothera...
Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center